Clinical Trials Browser

Terminated × Cholangiocarcinoma × Ipilimumab × Clear all

NCT05220722 2025-10-23

Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma